Scientists have achieved unprecedented success in correcting genetic mutations responsible for sickle cell disease and beta-thalassemia, marking a historic milestone in gene therapy that could benefit hundreds of millions worldwide and fundamentally alter how we approach heritable disorders.
Researchers at Johns Hopkins identify specific bacterial strains that dramatically improve checkpoint inhibitor efficacy in melanoma patients, opening a new avenue for microbiome-targeted adjuvant therapies.
Large-scale GWAS studies enable clinicians to identify patients at high risk for cardiovascular disease and type 2 diabetes with unprecedented accuracy.
Building on COVID-19 vaccine success, Moderna and BioNTech advance individualized cancer vaccines with promising Phase II results.
Phase I results from Mayo Clinic demonstrate that dasatinib & quercetin combination therapy safely reduces senescent cell burden with measurable functional improvements in older adults.
A convolutional neural network trained on 50,000 CT scans achieves 94% sensitivity in detecting sub-centimeter pulmonary nodules, surpassing specialist benchmarks.
Focused ultrasound combined with lipid nanoparticles enables transient, site-specific opening of the BBB, dramatically improving CNS drug bioavailability in primate models.
No queries yet. Be the first to ask!